IPSC Market Size | Insights, Trends & Growth Analysis 2025

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA10230

Publication Date: Oct 2025

What is the size of iPSC Market?

According to 6Wresearch internal database and industry insights, the iPSC Market was valued at USD 1.42 billion in 2024 and is expected to reach USD 6.45 billion by 2031, growing at a CAGR of 10.5% during 2025-2031.

Market growth is being fuelled by an increase in demand for personalised medicine, advances in regenerative therapies, and the increasing use of iPSCs in drug discovery, disease modelling, and as a novel therapeutic for genetic disease and other chronic conditions.

Growth Factors for iPSC Industry

Increasing demand for stem cell therapies and regenerative medicine
Increasing funding for stem cell-based research
Advances in gene-editing technologies and reprogramming methodologies
High utility of iPSCs in drug discovery and toxicology
Expanding use of iPSCs in personalised medicine and disease modelling

iPSC Market Trends

The iPSC market is trending in several areas, including an increased use of iPSCs in drug development, regenerative medicine, and disease modelling. Advances in genetic engineering techniques continue to enhance market growth. The growth of investments in stem cell research and product development is expected to enhance overall market dynamics. The adoption of iPSC-based therapeutics is also increasing as a means of treatment for genetic diseases and to improve drug testing.

Emerging Developments in the iPSC Market

Emerging developments in the iPSC market include innovations in gene editing and reprogramming techniques that enhance the efficiency of iPSC generation. Additionally, there is growing interest in the application of iPSCs for tissue engineering and regenerative therapies. Companies are focusing on improving the scalability of iPSC production for commercial applications. The increasing number of research partnerships and collaborations in the field is driving the acceleration of iPSC-based therapies and applications.